FDA Inspection
Siegfried Grafton, Inc.Siegfried Grafton, Inc. – FDA Inspection, Aug 21, 2026
Record Details
This FDA Inspection record concerns Siegfried Grafton, Inc., with an inspection on August 21, 2026, issued by the Minneapolis District Office, covering human drugs.
- People
- Adele I. Werner (Issuing Officer)
- Elizabeth R. Bloom (Issuing Officer)
- Joshua F. Blank (Issuing Officer)
View Company Profile
ID · 3b3cfabb-884c-434a-b6e3-ed336dcaf903
Inspection Facts
- Inspection number
- 1335886
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Siegfried Grafton, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 15, 2016 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| April 4, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 10, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Siegfried Grafton, Inc.
- FDA Inspection 1234253 - 2024-08-14
- FDA Inspection 981372 - 2016-07-15
- FDA Inspection 826305 - 2013-04-04
- FDA Inspection 732143 - 2011-06-10
- FDA Inspection 683854 - 2010-09-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.